CompletedNot Applicable

More Than Just p-Values: MCID for the VAS, MSQ and FEMD in Patients With Primary Dysmenorrhea

Turkey (Türkiye)100 participantsStarted 2025-02-15

Plain-language summary

The aim of this study is to determine the Minimal Clinically Important Difference (MCID) for the Visual Analog Scale (VAS), Menstrual Symptom Questionnaire (MSQ), and Functional and Emotional Measure of Dysmenorrhea (FEMD) in patients with primary dysmenorrhea (PwPD).

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of PD according to the "No. 345-Primary Dysmenorrhea Consensus Guideline", * Pain level of three or more according to VAS during activity (moderate to severe pain), * Patients aged 18-35 years (when PD becomes more prevalent), * Regular menstrual cycle with a duration of 28±7 days, * Nulliparity. Exclusion Criteria: * Historical background of chronic urogenital infections or drug use, * Pregnancy, * Secondary dysmenorrhoea caused by gynaecological conditions such as endometriosis, adenomyosis and uterine fibroids.

What they're measuring

Pain Intensity

Timeframe: Baseline (On the most painful day of the menstrual cycle before the intervention)

Pain Intensity

Timeframe: After the 4-week intervention (On the most painful day of the first menstrual cycle after the start of the intervention)

Pain Intensity

Timeframe: After the 8-week intervention (On the most painful day of the second menstrual cycle after the start of the intervention)

Trial details

NCT IDNCT06835036

SponsorArtvin Coruh University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-03

View on ClinicalTrials.gov More Primary Dysmenorrhea trials